INHIBIKASE THERAPEUTICS, INC.At the Market Offering Agreement • February 1st, 2024 • New York
Contract Type FiledFebruary 1st, 2024 JurisdictionWe have entered into an At the Market Offering Agreement, or the Sales Agreement, with H.C. Wainwright & Co., LLC, or Wainwright, relating to shares of our common stock offered by this prospectus supplement and the accompanying prospectus. In accordance with the terms of the Sales Agreement, we may offer and sell shares of our common stock, $0.001 par value per share, having an aggregate offering price of up to $5,659,255 from time to time through Wainwright acting as our agent.